破坏海洛因相关的记忆再巩固,通过抑制核中核中核中的actin聚合,破坏了海洛因相关的记忆再巩固
Haiting Zhao1,2, Haoyu Li1,3, Li Meng1,4
1National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.
The international journal of neuropsychopharmacology
|December 24, 2024
概括
在记忆再巩固过程中抑制actin聚合,显著减少了寻找海洛因的行为. 这种有针对性的干预,当在回忆检索后立即应用时,为预防成复发提供了潜在的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 成研究 研究成研究
背景情况:
- 吸毒成是一种学习障碍,其中线索引发渴望.
- 活性蛋白聚合对于形成与药物相关的记忆至关重要.
- 雅丁在重新巩固海洛因记忆中的作用尚不清楚.
研究的目的:
- 为了研究actin聚合在重新巩固与海洛因相关的记忆中的作用.
- 为了确定抑制actin聚合能否减少寻找海洛因的行为.
主要方法:
- 使用一种动物模型,自给海洛因和有条件的线索.
- 将actin聚合抑制剂Latrunculin A (Lat A) 输入到核心核 (NACc) 中.
- 拉特A在检索后立即使用,在检索后6小时使用,或没有检索试验.
主要成果:
- 恢复后的立即LATA管理显著减少了至少28天的诱导和海洛因诱导的海洛因寻找行为的恢复.
- 拉特A在检索后6小时内或没有检索试验后给药并没有影响寻找海洛因的行为.
- 在记忆重新激活之前服用的jasplakinolide也没有显示任何效果.
结论:
- 在记忆再巩固窗口期间抑制actin聚合会破坏与海洛因相关的记忆再巩固.
- 这种干扰导致海洛因寻找行为减少,并防止复发.
- 治疗效果取决于记忆检索,并显示时间特异性.
相关概念视频
Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...


